Biofrontera Inc. Profile Avatar - Palmy Investing

Biofrontera Inc.

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in co…

Drug Manufacturers - Specialty & Generic
US, Woburn [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Biofrontera Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Biofrontera Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Biofrontera Inc..

End of BFRI's Analysis
CIK: 1858685 CUSIP: 09077D100 ISIN: US09077D2099 LEI: - UEI: -
Secondary Listings
BFRI has no secondary listings inside our databases.